Literature DB >> 22591903

Novel methodologies for assessing omega-3 fatty acid status - a systematic review.

Mario Klingler1, Berthold Koletzko.   

Abstract

Over the last few decades n-3 long chain polyunsaturated fatty acid status became of special interest for scientists. Biochemical measures on the n-3 fatty acid status vary depending on body compartment assessed and measures chosen. Plasma phospholipids and red blood cell membrane phospholipids are mainly used as n-3 fatty acid status marker. The conventional analysis of phospholipid fatty acids involves lipid extraction and consecutive chromatographic separation of phospholipids from other lipid fractions, which is time-consuming and costly. In recent years, different investigators have tried to overcome these limitations by using other biological markers or by modifying the analytical procedures used to assess n-3 fatty acid status. The aim of this systematic review was to provide an overview on these novel analytical methods developed for the fatty acid quantification by gas chromatography, highlights the methodological limitations, and discusses advantages or disadvantages of the biological markers used. Seventeen papers were identified that fulfilled the inclusion criteria. New opportunities arise from sensitive and precise high-throughput methodologies for assessment of plasma total lipid and plasma glycerophospholipid fatty acids, as well as cheek cell fatty acid composition.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22591903     DOI: 10.1017/S0007114512001468

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  8 in total

1.  Total Serum Fatty Acid Analysis by GC-MS: Assay Validation and Serum Sample Stability.

Authors:  Jianwei Ren; Ellen L Mozurkewich; Ananda Sen; Anjel M Vahratian; Thomas G Ferreri; Alexander N Morse; Zora Djuric
Journal:  Curr Pharm Anal       Date:  2013       Impact factor: 0.890

2.  Omega-3 fatty acids moderate effects of physical activity on cognitive function.

Authors:  Regina L Leckie; Stephen B Manuck; Neha Bhattacharjee; Matthew F Muldoon; Janine M Flory; Kirk I Erickson
Journal:  Neuropsychologia       Date:  2014-05-09       Impact factor: 3.139

3.  Efficient and specific analysis of red blood cell glycerophospholipid fatty acid composition.

Authors:  Sabrina Klem; Mario Klingler; Hans Demmelmair; Berthold Koletzko
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

Review 4.  Considerations for Secondary Prevention of Nutritional Deficiencies in High-Risk Groups in High-Income Countries.

Authors:  Maaike J Bruins; Julia K Bird; Claude P Aebischer; Manfred Eggersdorfer
Journal:  Nutrients       Date:  2018-01-05       Impact factor: 5.717

5.  Cheek cell fatty acids reflect n-3 PUFA in blood fractions during linseed oil supplementation: a controlled human intervention study.

Authors:  Annemarie Grindel; Frank Staps; Katrin Kuhnt
Journal:  Lipids Health Dis       Date:  2013-11-14       Impact factor: 3.876

6.  Development and validation of a robust automated analysis of plasma phospholipid fatty acids for metabolic phenotyping of large epidemiological studies.

Authors:  Laura Yun Wang; Keith Summerhill; Carmen Rodriguez-Canas; Ian Mather; Pinal Patel; Michael Eiden; Stephen Young; Nita G Forouhi; Albert Koulman
Journal:  Genome Med       Date:  2013-04-25       Impact factor: 11.117

7.  B vitamin and/or n-3 fatty acid supplementation and health-related quality of life: ancillary findings from the SU.FOL.OM3 randomized trial.

Authors:  Valentina A Andreeva; Clotilde Latarche; Serge Hercberg; Serge Briançon; Pilar Galan; Emmanuelle Kesse-Guyot
Journal:  PLoS One       Date:  2014-01-17       Impact factor: 3.240

8.  Content of trans fatty acids in human cheek epithelium: comparison with serum and adipose tissue.

Authors:  Ransi A Abraham; Vinay K Bahl; Rajinder Parshad; V Seenu; Ambuj Roy; Smita Golandaz; Prabhakaran Dorairaj; Lakshmy Ramakrishnan
Journal:  Biomed Res Int       Date:  2013-10-08       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.